Vivo Opportunity Fund Holdings, L.P. - 17 Feb 2026 SCHEDULE 13G Report for Immunic, Inc. Common Stock, par value $0.0001 per share (IMUX)

Filing Manager
Vivo Opportunity Fund Holdings, L.P.
Reporting Manager
Vivo Opportunity Fund Holdings, L.P.
Security
Immunic, Inc. Common Stock, par value $0.0001 per share
Symbol
IMUX
Shares outstanding
291,560,621 shares
Disclosed Ownership
29,126,906 shares
Ownership
10%
Form type
SCHEDULE 13G
Filing time
20 Feb 2026, 16:43:57 UTC
Date of event
17 Feb 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Vivo Opportunity Fund Holdings, L.P. disclosed 10% ownership in Immunic, Inc. Common Stock, par value $0.0001 per share (IMUX) on 17 Feb 2026."

Quick Takeaways

  • Vivo Opportunity Fund Holdings, L.P. filed SCHEDULE 13G for Immunic, Inc. Common Stock, par value $0.0001 per share (IMUX).
  • Disclosed ownership: 10%.
  • Date of event: 17 Feb 2026.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 20 Feb 2026, 16:43.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Vivo Opportunity Fund Holdings, L.P. 10% 29,126,906 29,126,906 0 /s/ Kevin Dai Kevin Dai/Managing Member of Vivo Opportunity, LLC, General Partner
Vivo Opportunity, LLC 10% 29,126,906 29,126,906 0 /s/ Kevin Dai Kevin Dai/Managing Member
Vivo Opportunity Cayman Fund, L.P. 10% 2,942,094 2,942,094 0 /s/ Kevin Dai Kevin Dai/Managing Member of Vivo Opportunity Cayman, LLC, General Partner
Vivo Opportunity Cayman, LLC 10% 2,942,094 2,942,094 0 /s/ Kevin Dai Kevin Dai/Managing Member

Sponsored